122 related articles for article (PubMed ID: 7844983)
1. Immunohistochemical analysis of p53 in colorectal cancer regarding clinicopathological correlation and prognostic significance.
Tomoda H; Kakeji Y
J Surg Oncol; 1995 Feb; 58(2):125-8. PubMed ID: 7844983
[TBL] [Abstract][Full Text] [Related]
2. Immunohistological p53 staining is of limited value in the staging and prognostic prediction of colorectal cancer.
Kressner U; Lindmark G; Gerdin B; Påhlman L; Glimelius B
Anticancer Res; 1996; 16(2):951-7. PubMed ID: 8687158
[TBL] [Abstract][Full Text] [Related]
3. Morphological and immunohistochemical characterization of isolated tumor cells by p53 status in gastrointestinal tumors.
Milsmann C; Füzesi L; Heinmöller E; Krause P; Werner C; Becker H; Horstmann O
Langenbecks Arch Surg; 2008 Jan; 393(1):49-58. PubMed ID: 17876601
[TBL] [Abstract][Full Text] [Related]
4. Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes.
Kakeji Y; Korenaga D; Tsujitani S; Baba H; Anai H; Maehara Y; Sugimachi K
Br J Cancer; 1993 Mar; 67(3):589-93. PubMed ID: 8439509
[TBL] [Abstract][Full Text] [Related]
5. High expression of AT-rich interactive domain 3A (ARID3A) is associated with good prognosis in colorectal carcinoma.
Song M; Kim H; Kim WK; Hong SP; Lee C; Kim H
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S481-9. PubMed ID: 24366420
[TBL] [Abstract][Full Text] [Related]
6. Micrometastatic P53-positive cells in the lymph nodes of non-small-cell lung cancer: prognostic significance.
Dobashi K; Sugio K; Osaki T; Oka T; Yasumoto K
J Thorac Cardiovasc Surg; 1997 Sep; 114(3):339-46. PubMed ID: 9305185
[TBL] [Abstract][Full Text] [Related]
7. Micrometastatic p53-positive cells in the lymph nodes of early stage epithelial ovarian cancer: prognostic significance.
Suzuki M; Ohwada M; Saga Y; Kohno T; Takei Y; Sato I
Oncology; 2001; 60(2):170-5. PubMed ID: 11244333
[TBL] [Abstract][Full Text] [Related]
8. p53 expression in gastric cancer: clinicopathological correlation and prognostic significance.
Mönig SP; Eidt S; Zirbes TK; Stippel D; Baldus SE; Pichlmaier H
Dig Dis Sci; 1997 Dec; 42(12):2463-7. PubMed ID: 9440620
[TBL] [Abstract][Full Text] [Related]
9. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
Lopes A; Bezerra AL; Pinto CA; Serrano SV; de MellO CA; Villa LL
J Urol; 2002 Jul; 168(1):81-6. PubMed ID: 12050497
[TBL] [Abstract][Full Text] [Related]
10. p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer, and its prognostic significance.
Yamaguchi A; Nakagawara G; Kurosaka Y; Nishimura G; Yonemura Y; Miyazaki I
Br J Cancer; 1993 Aug; 68(2):399-402. PubMed ID: 8347496
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric examination of p53 protein in primary tumors and metastases to the liver and lymph nodes of colorectal cancer.
Kimura O; Sugamura K; Kijima T; Makino M; Shirai H; Tatebe S; Ito H; Kaibara N
Dis Colon Rectum; 1996 Dec; 39(12):1428-33. PubMed ID: 8969671
[TBL] [Abstract][Full Text] [Related]
12. EGFR, c-erbB2 and p53 protein in the primary lesions and paired metastatic regional lymph nodes in breast cancer.
Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y
Eur J Surg Oncol; 2002 Jun; 28(4):383-7. PubMed ID: 12099646
[TBL] [Abstract][Full Text] [Related]
13. Regional DNA content heterogeneity in colonic adenocarcinoma: prognostic significance in patients with liver metastases.
Graham RA; Teague K; Mclemore D; Cleary K; el-Naggar A
J Surg Oncol; 1992 Aug; 50(4):228-32. PubMed ID: 1640705
[TBL] [Abstract][Full Text] [Related]
14. p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study.
Goukon Y; Sasano H; Nishihira T; Nagura H; Mori S
Anticancer Res; 1994; 14(3B):1305-12. PubMed ID: 7915093
[TBL] [Abstract][Full Text] [Related]
15. [Expression of p53 protein in colorectal cancer and its relationship to cell proliferative activity and prognosis].
Gan H; Ouyang Q; Wang Y
Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):244-6. PubMed ID: 9387310
[TBL] [Abstract][Full Text] [Related]
16. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
[TBL] [Abstract][Full Text] [Related]
17. Assessment of biomarkers in paired primary and recurrent colorectal adenocarcinomas.
Seong J; Chung EJ; Kim H; Kim GE; Kim NK; Sohn SK; Min JS; Suh CO
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1167-73. PubMed ID: 10613309
[TBL] [Abstract][Full Text] [Related]
18. [DNA ploidy pattern and p53 overexpression in gastric cancer].
Tomisaki S; Tatsuo O; Hisao O; Sakaguchi Y; Kusumoto T; Ohno S; Ichiyoshi Y; Maehara Y; Sugimachi K
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():115-7. PubMed ID: 7611772
[TBL] [Abstract][Full Text] [Related]
19. p53 nuclear overexpression: an independent predictor of survival in lymph node--positive colorectal cancer patients.
Zeng ZS; Sarkis AS; Zhang ZF; Klimstra DS; Charytonowicz E; Guillem JG; Cordon-Cardo C; Cohen AM
J Clin Oncol; 1994 Oct; 12(10):2043-50. PubMed ID: 7931472
[TBL] [Abstract][Full Text] [Related]
20. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases.
McKay JA; Douglas JJ; Ross VG; Curran S; Ahmed FY; Loane JF; Murray GI; McLeod HL
Clin Cancer Res; 2000 Mar; 6(3):1113-8. PubMed ID: 10741741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
